Table 1 Disease group distribution of patients with SARS-COV- 2
Disease group | Diagnosis | Total N (%) |
|---|---|---|
SCD | SCD SS | 189 (27.8) |
SCD SC | 39 (5.7) | |
SCD SB0 | 19 (2.8) | |
SCD SB + | 22 (3.2) | |
SCD TOTAL | 269 (39.5) | |
TDT/NTDT | TDT/NTDT Major | 288 (42.3) |
TDT/NTDT Intermedia | 85 (12.5) | |
TDT/NTDT TOTAL | 373 (54.8) | |
Other RBCD | Diamond–Blackfan anemia (DBA) | 4 (0.6) |
Congenital dyserythropoietic anemia type II (CDAII) | 1 (0.1) | |
Elliptocytosis | 2 (0.3) | |
Glucose- 6-phosphate dehydrogenase deficiency (G6PD) | 3 (0.4) | |
High Affinity Hemoglobin | 1 (0.1) | |
Unstable Hemoglobin | 1 (0.1) | |
Pyruvate Kinase Deficiency (PKD) | 3 (0.4) | |
Hereditary spherocytosis | 24 (3.5) | |
Other RBC TOTAL | 39 (5.7) |